Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
metabiota [2022/08/22 17:41] pamela [USAID/Metabiota/Ecohealth Alliance megathread ((https://archive.ph/piWba#selection-647.1-649.165))] | metabiota [2022/12/07 02:33] (current) pamela [DTRA Funding] | ||
---|---|---|---|
Line 31: | Line 31: | ||
Wolfe’s company was also involved in the “Bellagio Initiative” within the [[:Global Virome Project]], once more, alongside [[:Peter Daszak]] of [[: | Wolfe’s company was also involved in the “Bellagio Initiative” within the [[:Global Virome Project]], once more, alongside [[:Peter Daszak]] of [[: | ||
- | [[:Jeffrey Epstein]] & [[: | + | [[:Jeffrey Epstein]] & [[: |
On August 22, 2017, Metabiota, the pioneer in epidemic risk modeling announced two market innovators, Munich Reinsurance Company, the world’s largest reinsurer and a leading expert on global risk solutions, and [[: | On August 22, 2017, Metabiota, the pioneer in epidemic risk modeling announced two market innovators, Munich Reinsurance Company, the world’s largest reinsurer and a leading expert on global risk solutions, and [[: | ||
Line 41: | Line 41: | ||
“The USA is gaining total control over biological research facilities, researchers and stocks of deadly viruses in Ukraine. This will allow the USA to control epidemiological situation in the region, get access to every development in the sphere and manipulate population size while increasing American pharmaceutical corporations’ profit. | “The USA is gaining total control over biological research facilities, researchers and stocks of deadly viruses in Ukraine. This will allow the USA to control epidemiological situation in the region, get access to every development in the sphere and manipulate population size while increasing American pharmaceutical corporations’ profit. | ||
- | “The Pentagon has got access to Ukrainian biological research facilities under the plausible pretext of preventing the proliferation of biological weapons. The biological projects are sponsored and supervised by the U.S. [[:Defense Threat Reduction Agency]] | + | “The Pentagon has got access to Ukrainian biological research facilities under the plausible pretext of preventing the proliferation of biological weapons. The biological projects are sponsored and supervised by the U.S. Defense Threat Reduction Agency |
“The American engineering firm [[:Black & Veatch]] is covering construction and maintenance of biological facilities and conducting biological researches under special projects. By a lucky chance, Metabiota, a subcontractor, | “The American engineering firm [[:Black & Veatch]] is covering construction and maintenance of biological facilities and conducting biological researches under special projects. By a lucky chance, Metabiota, a subcontractor, | ||
- | From 2008 to 2017, Black & Veatch and DTRA signed contracts, estimated at $215.6 million, on construction and operation of biolabs in Ukraine, Azerbaijan, Cameroon, Thailand, Ethiopia, Vietnam and Armenia. Under the program in Georgia and Ukraine, the company Metabiota, Black & Veatch subcontractor, | + | From 2008 to 2017, Black & Veatch and [[:DTRA]] signed contracts, estimated at $215.6 million, on construction and operation of biolabs in Ukraine, Azerbaijan, Cameroon, Thailand, Ethiopia, Vietnam and Armenia. Under the program in Georgia and Ukraine, the company Metabiota, Black & Veatch subcontractor, |
- | The News Front article goes on to describe visits in March, May and June 2018 by a US delegation to Odessa, Kharkiv and Lviv respectively. The US delegation comprised US Embassy delegates and representatives of Black & Veatch subcontractors. The purpose was to implement a “system of pathogens control management” during which Black & Veatch gained access to “especially dangerous pathogens” at the disposal of the Ukrainian Ministry of Defence.((https:// | + | The News Front article goes on to describe visits in March, May and June 2018 by a US delegation to Odessa, Kharkiv and Lviv respectively. The US delegation comprised US Embassy delegates and representatives of Black & Veatch subcontractors. The purpose was to implement a “**system of pathogens control management**” during which Black & Veatch gained access to “especially dangerous pathogens” at the disposal of the [[:Ukrainian Ministry of Defence]].((https:// |
==== Biowarfare Experiments ==== | ==== Biowarfare Experiments ==== | ||
- | Dilyana Gaytandzhieva, | + | [[:Dilyana Gaytandzhieva]], a Bulgarian journalist, identified US biotech company Metabiota Inc. in an extremely detailed 2019 article as the main player in the Ukrainian labs.((https:// |
Biowarfare scientists, using diplomatic cover, test man-made viruses at Pentagon biolaboratories in 25 countries across the world, Dilyana Gaytandzhieva wrote in 2018. These US biolaboratories are funded by the Defence Threat Reduction Agency (“DTRA”) under a $ 2.1 billion military program – [[: | Biowarfare scientists, using diplomatic cover, test man-made viruses at Pentagon biolaboratories in 25 countries across the world, Dilyana Gaytandzhieva wrote in 2018. These US biolaboratories are funded by the Defence Threat Reduction Agency (“DTRA”) under a $ 2.1 billion military program – [[: | ||
Line 61: | Line 61: | ||
==== DTRA Funding ==== | ==== DTRA Funding ==== | ||
- | The US Company Metabiota Inc. has been awarded $18.4 million federal contracts under the Pentagon’s DTRA program in Georgia and Ukraine for scientific and technical consulting services. Metabiota services include global field-based biological threat research, pathogen discovery, outbreak response and clinical trials. Metabiota Inc. had been contracted by the Pentagon to perform work for DTRA before and during the Ebola crisis in West Africa and was awarded $3.1 million (2012-2015) for work in Sierra Leone – one of the countries at the epicenter of the [[:Ebola]] outbreak.((https:// | + | The US Company Metabiota Inc. has been awarded $18.4 million federal contracts under the Pentagon’s DTRA program in Georgia and Ukraine for scientific and technical consulting services. |
- | The exact amount of funds that Carroll diverted from USAID’s pandemic program to set up the GVP remains unclear. In their release of documents, US Right to Know published a spreadsheet showing that $270,969 in USAID PREDICT funds were diverted to the GVP. However, other internal emails show USAID [[: | + | The exact amount of funds that Carroll diverted from USAID’s pandemic program to set up the GVP remains unclear. In their release of documents, US Right to Know published a spreadsheet showing that $270,969 in USAID [[:PREDICT]] funds were diverted to the GVP. However, other internal emails show USAID [[: |
“I plan on obligating those funds to Metabiota as soon as the balance of our [year 5] obligation is received by USAID, but please let me know if this is unacceptable, | “I plan on obligating those funds to Metabiota as soon as the balance of our [year 5] obligation is received by USAID, but please let me know if this is unacceptable, | ||
- | To this day, the financial supporters of the Global Virome Project are uknown. In early 2019, Edward “Eddy” Rubin of Metabiota emailed fellow GVP board member Jonna Mazet of UC Davis, as well as Dennis Carroll at USAID, to complain that the GVP was not finding backers. | + | To this day, the financial supporters of the [[:Global Virome Project]] are uknown. In early 2019, Edward “Eddy” Rubin of Metabiota emailed fellow GVP board member Jonna Mazet of UC Davis, as well as Dennis Carroll at [[:USAID]], to complain that the GVP was not finding backers. |
“USAID while supportive may not going forward be our champion, | “USAID while supportive may not going forward be our champion, | ||
Line 80: | Line 80: | ||
==== Hunter Biden Connection ==== | ==== Hunter Biden Connection ==== | ||
- | [[:Rosemont Seneca]] Technology Partners (RSTP) – a subsidiary of the [[:Hunter Biden]] and [[: | + | [[:Rosemont Seneca Technology Partners]] (RSTP) – a subsidiary of the [[:Hunter Biden]] and [[: |
Amongst the companies listed on archived versions of the RSTP’s portfolio is Metabiota – an ostensibly San Francisco-based company that purports to detect, track, and analyze emerging infectious diseases. | Amongst the companies listed on archived versions of the RSTP’s portfolio is Metabiota – an ostensibly San Francisco-based company that purports to detect, track, and analyze emerging infectious diseases. |